Cargando...

Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State

OBJECTIVE: To evaluate the expected cost-effectiveness and net benefit of the recent implementation of newborn screening (NBS) for severe combined immunodeficiency (SCID) in Washington State. STUDY DESIGN: We constructed a decision analysis model to estimate the costs and benefits of NBS in an annua...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Pediatr
Main Authors: Ding, Yao, Thompson, John D., Kobrynski, Lisa, Ojodu, Jelili, Zarbalian, Guisou, Grosse, Scott D.
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4846488/
https://ncbi.nlm.nih.gov/pubmed/26876279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2016.01.029
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!